Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer
Jose L. Dominguez-Escrig, John D. Kelly, David E. Neal, Sonya M. King, Barry R. Davies
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Evaluation of the therapeutic potential of the epidermal growth factor receptor tyrosine kinase inhibitor gefitinib in preclinical models of bladder cancer'. Together they form a unique fingerprint.